Lallemand Bio-Ingredients is pleased to announce that Gastro-AD® has received an additional health claim from Health Canada (NPN 80112011), recognizing its ability to help relieve symptoms associated with functional dyspepsia.
The newly approved claim broadens the recognized benefits of Gastro-AD®, supporting its use to help relieve symptoms associated with functional dyspepsia, including:
• Heartburn and acid reflux
• Bloating
• Nausea
• Vomiting
• Stomach rumbling
• Abdominal pain
This new Canadian health claim further reinforces the growing body of scientific evidence supporting Gastro-AD® and its ability to help soothe a wide range of uncomfortable gastrointestinal symptoms. It complements the product’s existing Health Canada-approved claim: “Helps support intestinal/gastrointestinal health.”
Nassim Naderi, Regulatory Affairs Specialist, Lallemand Bio-Ingredients says:
“The approval of this additional health claim by Health Canada represents an important milestone for Gastro-AD®. It reflects the scientific evidence supporting its benefits in helping relieve symptoms associated with functional dyspepsia and further expands the recognized benefits of the product in Canada. This expanded claim strengthens the scientific and regulatory foundation of Gastro-AD® and further validates its position as a science-based, natural solution for gastrointestinal health.”
Gastro-AD® is a plant-based fermented postbiotic made from natural ingredients and contains no medicinal ingredients. Its benefits have been evaluated in clinical studies involving more than 900 participants, demonstrating an excellent safety and efficacy profile.
Lallemand recommends consuming Gastro-AD® in powder form, either by the teaspoon or as a convenient sachet. The ingredient can be easily formulated into finished products with a variety of flavors and sweeteners, offering flexibility for supplement manufacturers and consumers alike.
